PAI
Palo Alto Investors Portfolio holdings
AUM $470M
1-Year Return
2.57%
This Quarter Return
-3.89%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.66B
AUM Growth
-$158M
(-8.7%)
Cap. Flow
-$19.7M
Cap. Flow
% of AUM
-1.19%
Top 10 Holdings %
Top 10 Hldgs %
76.19%
Holding
43
New
1
Increased
5
Reduced
3
Closed
1
Top Buys
| 1 |
AstraZeneca
AZN
|
+$12.1M |
| 2 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
+$10.5M |
| 3 |
Alkermes
ALKS
|
+$3.17M |
| 4 |
Amicus Therapeutics
FOLD
|
+$1.07M |
| 5 |
Syndax Pharmaceuticals
SNDX
|
+$837K |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$17.4M |
| 2 |
STAAR Surgical
STAA
|
+$16.4M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$11.1M |
| 4 |
Prothena Corp
PRTA
|
+$3.29M |
Sector Composition
| 1 | Healthcare | 96.14% |
| 2 | Financials | 2.8% |
